BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/26/2018 12:26:34 AM | Browse: 1360 | Download: 1503
 |
Received |
|
2018-03-27 10:03 |
|
Peer-Review Started |
|
2018-03-27 10:22 |
|
To Make the First Decision |
|
2018-04-19 01:29 |
|
Return for Revision |
|
2018-04-21 09:16 |
|
Revised |
|
2018-05-10 21:20 |
|
Second Decision |
|
2018-06-01 09:42 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-06-01 18:29 |
|
Articles in Press |
|
2018-06-01 18:29 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-06-25 07:05 |
|
Publish the Manuscript Online |
|
2018-06-26 00:26 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Hepatitis C virus infection in children in the era of direct-acting antiviral
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Malgorzata Pawlowska, Malgorzata Sobolewska-Pilarczyk and Krzysztof Domagalski |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Malgorzata Pawlowska, MD, PhD, Professor, Department of Paediatric Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University Torun, Floriana 12, Bydgoszcz 85-030, Poland. mpawlowska@cm.umk.pl |
| Key Words |
Biomarkers of liver injury; Adolescents; Epidemiology; Direct-acting antiviral; Hepatitis C virus; Non-invasive methods; Children |
| Core Tip |
There are more than 11 million hepatitis C virus (HCV)-infected children worldwide. Most new HCV-infected cases have occurred through vertical transmission. Currently, a new era of highly effective direct-acting antiviral agents for the treatment of HCV infection has begun for paediatric patients. The first results of clinical trials with interferon-free therapy are very promising. ESPGHAN developed a position paper for the management of chronic HCV infection in children. Non-invasive methods to measure hepatic fibrosis enable the identification of patients with significant liver fibrosis. This article summarizes the current data on epidemiology, new therapies and non-invasive methods in paediatric patients with HCV infection. |
| Publish Date |
2018-06-26 00:26 |
| Citation |
Pawlowska M, Sobolewska-Pilarczyk M, Domagalski K. Hepatitis C virus infection in children in the era of direct-acting antiviral. World J Gastroenterol 2018; 24(24): 2555-2566 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i24/2555.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i24.2555 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
